Neely Mozaffarian

Company: Ouro Medicines

Job title: Head Chief Marketing Officer, Development

Seminars:

Reprogramming Autoimmunity Through Selective B Cell Depletion with T-Cell Engagers 4:30 pm

Understanding target expression of BCMA in the context of autoimmune diseases Targeting long-lived, autoreactive B cells with OM336 to induce a selective and durable immune reset Characterizing immune reconstitution post-depletion to distinguish pathogenic memory B cell recovery from protective naive repopulation Understanding dynamics of response to BCMA-targeted therapy vs CD19-targeted therapyRead more

day: Day One